Victor Huang, MD
An Open-Label Pilot Study of Abatacept (CTLA4-Ig) for the Treatment of Nonsegmental Vitiligo
Tag Archive for: Symposium
Iltefat H. Hamzavi, MD, FAAD Oral Abstract
Analysis of 24-Week Response to Ruxolitinib Cream for the Treatment of Vitiligo Based on Patient Demographics and Clinical Characteristics
Nanja van Geel, MD, PhD
International Collaborative Project to Standardize the Assessment and Monitoring of Vitiligo in Clinical Trials, Registries and Clinical Practice
Julien Seneschal, MD, PHD
Vitiligo: Looking at the Memory T Cell Response
Jesslyn Alyce Magee, MS
Pilot Network Model for Automated Vitiligo Lesion Segmentation: Promise and Challenges
Nanja van Geel, MD, PhD – Oral Abstract
Influencing Factors on the Patient Global Assessment Score for Vitiligo Severity
Pearl Grimes, MD
Effects of Ruxolitinib Cream on Affected Body Areas in Patients with Vitiligo: Subgroup Analysis from a 52-Week, Randomized, Double-Blind Trial
John E. Harris, MD, PhD
Advances In Immune Mechanisms Of Vitiligo
